Cargando…

Management of Lobular Neoplasia Diagnosed by Core Biopsy

Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Becau...

Descripción completa

Detalles Bibliográficos
Autores principales: Jani, Chinmay, Lotz, Margaret, Keates, Sarah, Gupta, Yasha, Walker, Alexander, Al Omari, Omar, Parvez, Arshi, Patel, Dipesh, Gnata, Maria, Perry, John, Khorashadi, Leila, Weissmann, Lisa, Pories, Susan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129432/
https://www.ncbi.nlm.nih.gov/pubmed/37114120
http://dx.doi.org/10.1155/2023/8185446
_version_ 1785030736463527936
author Jani, Chinmay
Lotz, Margaret
Keates, Sarah
Gupta, Yasha
Walker, Alexander
Al Omari, Omar
Parvez, Arshi
Patel, Dipesh
Gnata, Maria
Perry, John
Khorashadi, Leila
Weissmann, Lisa
Pories, Susan E.
author_facet Jani, Chinmay
Lotz, Margaret
Keates, Sarah
Gupta, Yasha
Walker, Alexander
Al Omari, Omar
Parvez, Arshi
Patel, Dipesh
Gnata, Maria
Perry, John
Khorashadi, Leila
Weissmann, Lisa
Pories, Susan E.
author_sort Jani, Chinmay
collection PubMed
description Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences.
format Online
Article
Text
id pubmed-10129432
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-101294322023-04-26 Management of Lobular Neoplasia Diagnosed by Core Biopsy Jani, Chinmay Lotz, Margaret Keates, Sarah Gupta, Yasha Walker, Alexander Al Omari, Omar Parvez, Arshi Patel, Dipesh Gnata, Maria Perry, John Khorashadi, Leila Weissmann, Lisa Pories, Susan E. Breast J Research Article Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences. Hindawi 2023-04-18 /pmc/articles/PMC10129432/ /pubmed/37114120 http://dx.doi.org/10.1155/2023/8185446 Text en Copyright © 2023 Chinmay Jani et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jani, Chinmay
Lotz, Margaret
Keates, Sarah
Gupta, Yasha
Walker, Alexander
Al Omari, Omar
Parvez, Arshi
Patel, Dipesh
Gnata, Maria
Perry, John
Khorashadi, Leila
Weissmann, Lisa
Pories, Susan E.
Management of Lobular Neoplasia Diagnosed by Core Biopsy
title Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_full Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_fullStr Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_full_unstemmed Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_short Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_sort management of lobular neoplasia diagnosed by core biopsy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129432/
https://www.ncbi.nlm.nih.gov/pubmed/37114120
http://dx.doi.org/10.1155/2023/8185446
work_keys_str_mv AT janichinmay managementoflobularneoplasiadiagnosedbycorebiopsy
AT lotzmargaret managementoflobularneoplasiadiagnosedbycorebiopsy
AT keatessarah managementoflobularneoplasiadiagnosedbycorebiopsy
AT guptayasha managementoflobularneoplasiadiagnosedbycorebiopsy
AT walkeralexander managementoflobularneoplasiadiagnosedbycorebiopsy
AT alomariomar managementoflobularneoplasiadiagnosedbycorebiopsy
AT parvezarshi managementoflobularneoplasiadiagnosedbycorebiopsy
AT pateldipesh managementoflobularneoplasiadiagnosedbycorebiopsy
AT gnatamaria managementoflobularneoplasiadiagnosedbycorebiopsy
AT perryjohn managementoflobularneoplasiadiagnosedbycorebiopsy
AT khorashadileila managementoflobularneoplasiadiagnosedbycorebiopsy
AT weissmannlisa managementoflobularneoplasiadiagnosedbycorebiopsy
AT poriessusane managementoflobularneoplasiadiagnosedbycorebiopsy